Article

Drug Repurposing of potential drug targets for treatment of COVID-19

2021-06-08

Abstract excerpt

Drug repurposing has the potential to bring existing de-risked drugs for effective intervention in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million people succumbing to the illness globally (as of April 04, 2021). We have used a novel `gene signature’-based drug repositioning strategy by applying widely accepted gene ranking algorithms to prioritize the FDA approved or under trial...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7bc1e933-2130-516c-91ea-86825a7ccdb6
DOI: 10.1101/2021.06.02.21258223

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drug Repurposing of potential drug targets for treatment of COVID-19DOI 10.1101/2021.06.02.21258223Read

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisSemantic proximity Read

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read

Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity Read

Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein InteractomeSemantic proximity Read

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read

Bioinformatic approaches towards identification of potential repurposable drugs for COVID-19Semantic proximity Read

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic DataSemantic proximity Read

Drug Target Set Enrichment Analysis (DTSEA): A Network-Based Approach for Drug Repurposing to COVID-19Semantic proximity Read

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity Read

Systematic Down-Selection of Repurposed Drug Candidates for COVID-19Semantic proximity Read